Skip to main content
TipRanks
Go Ultimate75% OFF

Clearbridge Health Ltd. (5C6) AI Stock Analysis

0 Followers
DE:5C6

Clearbridge Health Ltd.

(Frankfurt:5C6)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue ReboundThe 2025 revenue rebound indicates renewed demand for the company’s diagnostic and screening services after earlier weakness. If maintained, a larger revenue base could improve operating leverage, support investment in service capacity, and provide a foundation for restoring profitability over the next several quarters.
Negative Factors
Persistent Net LossesPersistent losses, including a substantial widening in 2025, show that revenue growth has not yet translated into a sustainable earnings model. Continued losses can constrain reinvestment, weaken financial resilience, and make future performance increasingly dependent on a successful reduction in operating costs.

Clearbridge Health Ltd. (5C6) vs. iShares MSCI Germany ETF (EWG)

Not enough price history over this period.

Market Cap
EUR 4.54M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.3
Beta (1Y)
-0.45
Revenue Growth
―
EPS Growth
―
Country
Germany
Employees
113
Sector
Healthcare
Sector Strength
51
Industry
Medical - Diagnostics & Research

Clearbridge Health Ltd. Business Overview & Revenue Model

Company Description

Established in 2010 and headquartered in Singapore, Clearbridge Health Limited operates as an investment holding company, delivering diverse healthcare solutions globally, including in Singapore, the Philippines, Hong Kong, and Malaysia. The firm's a...

Clearbridge Health Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

DE:5C6 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SG:OTXSG:OTX84OutperformSGD 26.91M8.7219.60%7.64%-3.11%-21.50%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SG:V8YSG:V8Y42NeutralSGD 12.59M-3.33118.31%―2.08%-50.00%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%75%SG:505SG:584SG:MIJSG:OTXDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:5C6 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:5C6Clearbridge Health Ltd.―――
SG:505Asiamedic Limited0.02-0.00-5.26%
SG:584AJJ Medtech Holdings Limited0.010.000.00%
SG:MIJAlliance Healthcare Group Ltd.0.180.0655.17%
SG:OTXMedinex Ltd.0.22-0.00-1.35%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.